As of Friday, December 19, Cassava Sciences, Inc.’s SAVA share price has dipped by 17.37%, which has investors questioning if this is right time to buy.

Cassava Sciences SAVA recently suffered yet another setback, which raises concern regarding its prospects. Last week, the company announced that the phase III study REFOCUS-ALZ on lead pipeline ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

A downtrend has been apparent in Cassava Sciences, Inc. (SAVA) lately with too much selling pressure. The stock has declined 83.9% over the past four weeks. However, given the fact that it is now in ...

Both gravel bikes and electric bikes are becoming more popular, so it should come as no surprise that we're seeing an increasing number of gravel ebikes. One of the latest, the E-Flash, features a ...

Shares of Cassava Sciences SAVA plunged 32.1% on Tuesday after the company announced that its lead pipeline candidate, simufilam, failed to meet the prespecified co-primary endpoints in the second ...

An Immersive Experience Designed to Empower a Higher State of Consciousness NEW YORK--(BUSINESS WIRE)--TERSA, the pioneering wellness company dedicated to reinventing holistic human health and high ...

I love SAVA’s concept— curated cannabis. It means something to me to learn from others. I don't know everything, far from. So, when I discovered the "curated" approach that SAVA takes, they certainly ...